Tom Newsom-Davis Profile Banner
Tom Newsom-Davis Profile
Tom Newsom-Davis

@tnewsomdavis

Followers
2,206
Following
214
Media
851
Statuses
2,590

Thoracic medical oncologist | Consultant @ChelwestFT | Chair Elect @BTOGorg |

London, England
Joined June 2014
Don't wanna be here? Send us removal request.
Explore trending content on Musk Viewer
@tnewsomdavis
Tom Newsom-Davis
7 months
@bbcnickrobinson As an oncologist, I know that a cancer diagnosis should be private if that is what the patient wants. It doesn’t matter who you are. This is unarguable. Those who spread rumours and force the loss of that privacy should be ashamed of themselves.
48
429
4K
@tnewsomdavis
Tom Newsom-Davis
3 years
@ZiziFothSi But in the brainstem, we have cute puppies
Tweet media one
14
94
3K
@tnewsomdavis
Tom Newsom-Davis
2 years
👉 Things you learnt about in medical school but almost never see in practice Here’s my offering from clinic today No prizes for diagnosis What’s your example?
Tweet media one
41
21
184
@tnewsomdavis
Tom Newsom-Davis
2 years
People having poster nightmares, a series. I feel your pain. We’ve all been there.
Tweet media one
Tweet media two
Tweet media three
Tweet media four
11
9
170
@tnewsomdavis
Tom Newsom-Davis
2 years
Activity of ALK TKIs still stops me in my tracks after all these years. Astounding. Before (L) and after (R) 3 month’s Alectinib @ALKpositiveINT @ALKLungCancer [Images with patients permission]
Tweet media one
7
18
156
@tnewsomdavis
Tom Newsom-Davis
1 year
Can’t claim responsibility for this, and thank you for person who sent it to me, but reckon this is the most useful #ASCO23 list there is: Free food available in Exhibition Hall:
Tweet media one
15
14
132
@tnewsomdavis
Tom Newsom-Davis
1 year
DOACs and lung cancer TKIs: I had no ideas that DDIs were so marked and ubiquitous. Fantastic open-access review here from Dr Otten and colleagues: I will be printing this out & sticking it on my clinic desk. #LCSM @BTOGORG
Tweet media one
6
52
124
@tnewsomdavis
Tom Newsom-Davis
3 years
Anyone else always see a smiling bat with wings, when looking at bone windows of a CT pelvis?
Tweet media one
17
3
119
@tnewsomdavis
Tom Newsom-Davis
3 years
First patient on Sotorasib = first response to Sotorasib. Seeing new drugs work in lung cancer is still the most exciting thing there is. (3 months between scans. Images with patient’s permission) #LCSM
Tweet media one
Tweet media two
6
15
101
@tnewsomdavis
Tom Newsom-Davis
2 years
Sure, @ASCO and @myESMO have more attendees. But we win in the party & dancing competition 🕺 💃 #BTOG23
8
3
98
@tnewsomdavis
Tom Newsom-Davis
4 years
And so it starts: Acute Oncology inpatient list has gone from <1 page to 3 pages in past week. Great majority COVID -ve. Large number of Emergency Presentations of new cancer, as we suspected would happen.
8
36
86
@tnewsomdavis
Tom Newsom-Davis
4 years
@drphiliplee1 Followed by this when they realise you have forgotten to sign it (and you are 4 floors upstairs)
Tweet media one
0
2
85
@tnewsomdavis
Tom Newsom-Davis
5 months
Osimertinib use associated with nutritional deficiencies ❗️Significant deficiencies of Vit B, Vit D, Iron, Vit B12 ❓May reflect GI side effects of drug 🤔 Should screen for these during Osimertinib treatment: quick and cheap to do #ASCO24 #LCSM
Tweet media one
5
34
82
@tnewsomdavis
Tom Newsom-Davis
3 years
Requesting NGS after NSCLC patient has started platinum chemotherapy
Tweet media one
2
10
81
@tnewsomdavis
Tom Newsom-Davis
6 months
Mariana Brandao: What defines operable NSCLC? EORTC consensus guidelines: 🔸 T3N1 = ✅ (resectable) 🔸T3 single station N2 = ✅ 🔸T3 multi-station N2 = ❌ 🔸T3 Bulky N2 = most ❌ 🔸T4 N0/1 = ✅, unless infiltration of major structures #LCSM #BTOG24
Tweet media one
2
27
80
@tnewsomdavis
Tom Newsom-Davis
3 years
‼️ Sotorasib approved by NHS for KRAS G12C NSCLC ‼️ 2nd lung cancer drug via Project Orbis. This is a good news day.
2
15
78
@tnewsomdavis
Tom Newsom-Davis
1 year
Oncologist hearing acute medic referring to patient’s TKI as ‘immunotherapy’ #LCSM
Tweet media one
3
4
77
@tnewsomdavis
Tom Newsom-Davis
1 year
The Holy Trinity of lung oncology
Tweet media one
1
4
76
@tnewsomdavis
Tom Newsom-Davis
10 months
Early Christmas present! Appointed to @IASLC Multidisciplinary Clinical Science Committee. Thank you IASLC. Looking forward to working with colleagues to develop world-class education and to answer the major research questions we face. 👊👊
Tweet media one
14
2
75
@tnewsomdavis
Tom Newsom-Davis
5 years
Who knew? UK is best at palliative care (we knew, of course). Palliative medicine an essential part of #BTOG20 . So pleased my colleagues Ruth Caulkin & Antonia Field-Smith are at their First BTOG.
Tweet media one
3
26
75
@tnewsomdavis
Tom Newsom-Davis
5 months
‼️ Ivonescimab (PD-1/VEGF) + chemo post Osimertinib ✅ ⬆️ PFS ❓ ⬆️ OS benefit (immature) ✅ ⬆️ ORR ✅ ⬆️ DoR ✅ Minor additional tox vs. chemo 🤔 Impressive PFS benefit: same as MARIPOSA-2 🤔 None of Amivantamab toxicity issues 🤔 Big challenge to Ami 🤜🤜 #ASCO24 #LCSM
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
26
75
@tnewsomdavis
Tom Newsom-Davis
6 years
Beautiful new @macmillancancer centre just opened on LG floor of @ChelwestFT . Excellent news for our patients.
Tweet media one
2
9
68
@tnewsomdavis
Tom Newsom-Davis
4 years
Today I had my first beer from a pub since March (outdoors, at a responsible 2m distance from all and sundry). I almost cried I was so happy.
Tweet media one
2
1
66
@tnewsomdavis
Tom Newsom-Davis
1 year
7th patient recruited to West London Genomics Medicine ctDNA pilot = first actionable 1L mutation. 👉 Report read by me this am. 👉 TKI lined up. 👉 Tissue NGS has only been requested today. 👍 This will cut 3-4 weeks off treatment timeline. 💥
Tweet media one
2
10
64
@tnewsomdavis
Tom Newsom-Davis
3 years
‼️ Adjuvant Atezolizumab (IMpower-010) approved by NHS England via Project Orbis‼️ Was so busy at #BTOG22 I completely missed this today
5
14
64
@tnewsomdavis
Tom Newsom-Davis
1 year
Emerging biomarkers in NSCLC: what will we be doing in the near future? Great review from Dr Paul Hofman #ILCS23
Tweet media one
2
24
62
@tnewsomdavis
Tom Newsom-Davis
1 year
One of the most intriguing findings in cancer immunotherapy. I can’t explain why it happens, but we now have repeated studies finding the same thing, even when confounding factors (age, PS) taken into account.
@BenjaminBesseMD
Benjamin Besse
1 year
Accumulative publications showing that immunotherapy is more potent when given early in the day. Time to change our practice and give our IOs in the morning? At least until evidence of a circadian biology supporting the hypothesis & availability of data from phase III trials?
Tweet media one
17
95
309
9
20
63
@tnewsomdavis
Tom Newsom-Davis
5 months
Osimertinib + SABR in EGFR+ 🔹 Osi x2m, SABR to all sites, cont Osi 👍 mPFS 32.3m 👍 mOS 45m 👍 mDuration on Osi 32.4m 👍 Low Gr3+ AE ❗️small numbers ❗️single arm study ❗️need details of SABR treatment 🤔 survival better than FLAURA 🤔 Pt selection key here #ASCO24 #LCSM
Tweet media one
Tweet media two
Tweet media three
1
32
62
@tnewsomdavis
Tom Newsom-Davis
6 years
Great summary of new targets in NSCLC from @dplanchard #ELCC2019 #LCSM
Tweet media one
1
26
61
@tnewsomdavis
Tom Newsom-Davis
1 year
Downloaded @escardio guidelines on cardio-oncology (great app) ✔️ Excellent flowchart on QTc intervals ❗️Keep K+ >4 and Mg >1.10 mmol/l ❗️<480msec is magic number ✅ ❗️>500msec is scary number ❌ 🙏 Great suggestion by Dr Alex Lyon @RBandH
Tweet media one
1
22
61
@tnewsomdavis
Tom Newsom-Davis
5 years
Weekly referrals to our @ChelwestFT Acute Diagnostic Oncology Clinic. Very worried: referrals have stopped with COVID. To our Primary Care friends: if you suspect cancer, please do not delay referral to appropriate clinic. Cancer still happens, despite COVID. @cwpluscharity
Tweet media one
3
54
55
@tnewsomdavis
Tom Newsom-Davis
4 years
Seen this poem on the tube for a few months now. Seems especially apt this week.
Tweet media one
2
18
56
@tnewsomdavis
Tom Newsom-Davis
2 years
Some advantages to working late: Cycle home through empty Richmond Park & 9pm sunset.
Tweet media one
2
3
59
@tnewsomdavis
Tom Newsom-Davis
2 years
KEYNOTE-789: Pem/Carbo vs. Pembro/Pem/Carbo post-TKIs in EGFR+ve 👉 Non significant OS benefit 👉 Non significant PFS benefit So if chemoIO preferred in this patient group, use IMPower150, not Pem/Pem/Carbo.
5
26
56
@tnewsomdavis
Tom Newsom-Davis
5 months
5yr outcomes of Checkmate-9LA (gosh, how time flies) Confirms better activity of dual immunotherapy in PD-L1 -ve population 22% 5yr OS is impressive in this poorer prognosis subgroup Abstract 8560 #ASCO24 #LCSM
Tweet media one
0
25
58
@tnewsomdavis
Tom Newsom-Davis
6 years
EMA approves atezolizumab, carboplatin, paclitaxel & bevacizumab (i.e. IMpower150) for 1st non-squamous NSCLC. Includes EGFR mutation & ALK positive patients (if failed prior TKIs).
0
24
57
@tnewsomdavis
Tom Newsom-Davis
1 year
‼️ NICE approve Selpercatinib ‼️ Make sure your molecular testing covers all fusions, including RET. Rare, but essential we find it when it is there.
Tweet media one
6
20
55
@tnewsomdavis
Tom Newsom-Davis
5 years
NICE approve IMpower150 (Atezolizumab, Carboplatin, Paclitaxel, Bevacizumab) in: • 1L, nonsquamous, PD-L1 0-49% • EGFR or ALK mutation post TKI failure (no mention of PD-L1 cut-off) Good news for our patients. Post-EGFR and ALK indication especially interesting.
5
15
56
@tnewsomdavis
Tom Newsom-Davis
6 years
Very excited to be appointed Vice Chair of BTOG Steering Committee. Thank you @BTOGORG @DrSanjayPopat and @_johnedwards for your votes of confidence.
6
6
53
@tnewsomdavis
Tom Newsom-Davis
2 years
@gerryhanna @ASCO Can you change badges according to who is approaching you?
1
0
49
@tnewsomdavis
Tom Newsom-Davis
1 year
Wow. Check out how many KRAS inhibitors are currently in trials 🤯 Beautifully clear summary from Tina Cascone #ILCS23 @KRASKickers
Tweet media one
1
18
52
@tnewsomdavis
Tom Newsom-Davis
2 years
Errr… I think the correct term is ‘Specialist Palliative Medicine Physician’ Cerner strikes again!
Tweet media one
2
0
52
@tnewsomdavis
Tom Newsom-Davis
4 years
Well, it’s been a great day 1 of #BTOG21 Delighted so many people registered, impressed with quality of talks, enjoyed Q&A sessions But... Should now be heading to the bar with friends and colleagues, not sitting at home doing my emails
Tweet media one
2
4
50
@tnewsomdavis
Tom Newsom-Davis
2 years
Off we go! First BTOG since January 2020! Yay! #BTOGSummerMeeting
Tweet media one
2
5
51
@tnewsomdavis
Tom Newsom-Davis
5 years
Alison runs our fantastic @macmillancancer centre @ChelwestFT Our patients will miss her but we know @NightingaleLDN needs her more. Not surprised Alison was amongst the first to volunteer: confirms the high esteem we all hold her in.
@ali09027
Ali Boyd
5 years
Induction complete, currently waiting for the rosta for the family communication and support team @NightingaleLDN #WhatATeam Our Macmillan centre is being looked after by my amazing centre volunteers who are answering any voicemails #Macmillan #Proud
Tweet media one
5
1
39
1
5
50
@tnewsomdavis
Tom Newsom-Davis
4 years
First Acute Oncology board round since COVID kicked off #gettingthebandbacktogether 🤗 @ChelwestFT
Tweet media one
2
1
50
@tnewsomdavis
Tom Newsom-Davis
5 years
Ph3 trials during COVID with teleconsultations reinforces wastefulness of study requirements every cycle: Full neuro exam: Why, if no symptoms? Clotting: Why, if no Ph2 concerns? 6 weekly scans: Why so often? Hope we learn from this and have better protocols in future.
2
10
51
@tnewsomdavis
Tom Newsom-Davis
5 years
In clinic, seeing new patients and teleconsultations for all others. Every patient lovely. Everyone so grateful. Everyone telling me they will be clapping at 8pm. And then free lunch box arrives, unrequested. 😊
Tweet media one
3
3
50
@tnewsomdavis
Tom Newsom-Davis
5 years
Who needs some good news? 🙋‍♂️ @NICEComms have approved Lorlatinib in relapsed ALK+ve NSCLC. @BTOGORG
Tweet media one
2
11
50
@tnewsomdavis
Tom Newsom-Davis
2 years
Lived in London for >40yrs Still surprises me with beautiful views
Tweet media one
5
1
50
@tnewsomdavis
Tom Newsom-Davis
5 years
2nd two slides that should be in every oncology clinic room this winter. Answer: ✅ Yes: Get a flu vaccine if your GP is offering it. ❌ No: It won’t stop immunotherapy working and is highly unlikely to cause you any problems. @BTOGORG #ESMOAsia19
@dplanchard
d.planchard
5 years
Practical questions with IO presented by @barlesi at #ESMOAsia19 @myESMO and clear messages, thank you !
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
33
49
1
25
49
@tnewsomdavis
Tom Newsom-Davis
1 year
PD-L1 high (50-89%) and very high (90%+) in 1L immunotherapy for NSCLC ✅ Better survival with both Cemiplimab and Pembrolizumab if PD-L1 90%+ ❗️Make sure your pathology report states exact PD-L1 figure, not just ‘>50%’ because details matter #WCLC23 #LCSM @BTOGORG
Tweet media one
Tweet media two
0
21
47
@tnewsomdavis
Tom Newsom-Davis
3 years
Surely should be renamed ‘Popat Player’? #BTOG22
Tweet media one
4
1
48
@tnewsomdavis
Tom Newsom-Davis
4 years
All set for ⁦ @BTOGORG ⁩ ‘ASCO in an Hour’ webinar: Laptop ✅ Headphones ✅ Cup of tea ✅ Kids banished upstairs ✅ Kick off in 30 mins >450 delegates Note to self: don’t muck it up
Tweet media one
6
1
48
@tnewsomdavis
Tom Newsom-Davis
4 years
Exactly 1 year after we moved out, when our chemotherapy unit was converted into a COVID ward, we are back in the Gazzard Day Unit. Our itinerant days are over. 🤗 ✅ all patients offered COVID vaccine ✅ all staff vaccinated ✅ all staff weekly PCR tested @ChelwestFT
Tweet media one
Tweet media two
1
2
46
@tnewsomdavis
Tom Newsom-Davis
3 years
#BTOG22 base all set up. Huge luxury to be able to spend 48hrs educating myself with the good and the great of lung oncology. Only thing missing is hangover from excess Guinness in Clayton bar from night before.
Tweet media one
7
2
46
@tnewsomdavis
Tom Newsom-Davis
5 years
More good news, folks? 🙋‍♂️ NICE approve Larotrectinib for advanced NTRK fusion cancer (adult & paediatric) via Cancer Drugs Fund. Challenge is now to get national testing in place and to find the patients. @GenomicsEngland @BTOGORG
3
8
46
@tnewsomdavis
Tom Newsom-Davis
2 years
This is great news, and not before time. Although it may sound trivial, in fact loss of driving license and associated independence is one of greatest quality of life issues I see for patients with CNS metastases.
@UKALK1
UKALK+
2 years
Today saw the DVLA agree to review current driving rules/restrictions with asymptomatic brain mets . They commented they had learnt a great deal from the @UKALK + panel and asked for a copy of our survey  #patientadvocacy #qualityoflife @LCN_UK @BTOGORG @EgfrUk @ros1dersuk
Tweet media one
2
6
27
3
1
46
@tnewsomdavis
Tom Newsom-Davis
2 years
Sad to read that Prof Kenneth Bagshawe has died. A true pioneer: He set up the first medical oncology unit in 🇬🇧, cured the first patient in Europe with choriocarcinoma, amongst many other achievements. @ACPUK
Tweet media one
0
11
45
@tnewsomdavis
Tom Newsom-Davis
5 years
Meeting @acmedsci this evening. Beautiful building and a great institution. Wandered upstairs to find a suite named after my dear dad, who sadly died 12 years ago. He would have been SO pleased!
Tweet media one
3
1
43
@tnewsomdavis
Tom Newsom-Davis
2 years
Sage words from @bengoldacre
Tweet media one
2
4
42
@tnewsomdavis
Tom Newsom-Davis
5 months
LAURA: Osimertinib after CRT for st 3 EGFR+ ✅ Massive PFS benefit HR= 0.16 ❗️Cntrl arm performs terribly ✅ Neuroprotective ❓OS immature ❗️81% x-over 🔺 48 v 38% pneumonitis, 2% Gr3 🤔 Practice changing 👏 👏 👏 🤔 PET not mandated, hence poor cntrl arm? #ASCO24 #LCSM
Tweet media one
Tweet media two
Tweet media three
Tweet media four
2
20
44
@tnewsomdavis
Tom Newsom-Davis
7 months
Great to see ⁦ @BBCNews ⁩ picking up this important good news story for lung cancer patients in England You can hear more about the pilot phase of this work at ⁦⁦ @BTOGORG ⁩ conference next month ⁦ @DrSanjayPopat
1
14
43
@tnewsomdavis
Tom Newsom-Davis
1 year
Delighted to be representing @BTOGORG at joint @Roy_Castle_Lung and @MSDintheUK reception in the House of Commons, hosted by Nicola Richards MP Focus on improving outcomes across the UK
Tweet media one
Tweet media two
2
1
43
@tnewsomdavis
Tom Newsom-Davis
5 years
Beautiful morning for 300th Westminster Hospital Anniversary at Westminster Abbey. Best venue I have ever been asked to speak at! #Westminster300 @cwpluscharity @ChelwestFT
Tweet media one
Tweet media two
Tweet media three
Tweet media four
2
10
41
@tnewsomdavis
Tom Newsom-Davis
5 years
Very proud to be presenting our Acute Diagnostic Oncology Clinic at #ESMO2019 Abhijit Gill showing the world how integrate primary care into hospital-based oncology to diagnose patients better and faster. @cwpluscharity @ChelwestFT @macmillancancer @CR_UK
Tweet media one
5
6
41
@tnewsomdavis
Tom Newsom-Davis
1 year
Great art installation from @cwpluscharity in outpatient corridor @ChelwestFT Camera tracks your movement and imposes it on the graphics Mesmerising Almost made me late for clinic
2
3
39
@tnewsomdavis
Tom Newsom-Davis
5 years
@DrSanjayPopat ⁩ addressing the plenary session. We have 1,000 delegates for the first time! #BTOG20
Tweet media one
1
6
38
@tnewsomdavis
Tom Newsom-Davis
5 months
🚨🚨 ADRIATIC: Durvalumab after cCRT in LS-SCLC ✅⬆️ OS HR 0.73 ✅⬆️ PFS HR 0.76 ✅ Small ⬆️ AE, but not Gr3+ ❗️Total pneumonitis 38 v 30% 👉46% PCI 🤔 Practice changing 👏 👏 👏 🤔 Rare OS improvement in SCLC 🤔 AE data reassuring 🤔 Need access now in 🇬🇧 #ASCO24 #LCSM
Tweet media one
Tweet media two
Tweet media three
Tweet media four
2
13
38
@tnewsomdavis
Tom Newsom-Davis
4 years
Landing page for virtual #BTOG2021 is the reception of the Clayton (aka Burlington) Hotel in Dublin. 😍 All kicks off at 9am tomorrow. If I could just turn right, I would be in the bar.
Tweet media one
5
0
36
@tnewsomdavis
Tom Newsom-Davis
5 years
Did you know.... PD-1 was first described in 1992? (The year I started medical school 😳) Slide thanks to @CelineMascaux #BTOG20 #LCSM
Tweet media one
5
11
36
@tnewsomdavis
Tom Newsom-Davis
1 year
👉 BiTE (bispecific T cell engager) in SCLC and other NETs: anti-DLL3 & CD3 👉 Welcome inclusion of LCNEC pts 🔺 53% Gr3-5 tox. 🔺 Cytokine release syndrome in 47% but mainly Gr 1-2 🔺ORR 26% in SCLC population mDoR and mPFS not reached #LCSM #WCLC23
Tweet media one
Tweet media two
Tweet media three
1
9
33
@tnewsomdavis
Tom Newsom-Davis
3 years
It’s been a good couple of days: 👍 Adjuvant immunotherapy approved 👍 Finished new raspberry cane bed (Who knew? No raspberry emoji!)
Tweet media one
3
0
36
@tnewsomdavis
Tom Newsom-Davis
2 years
Tweet media one
2
2
34
@tnewsomdavis
Tom Newsom-Davis
2 years
The Boss welcomes us all to #BTOG23
Tweet media one
1
3
34
@tnewsomdavis
Tom Newsom-Davis
1 year
I know I just passed my 50th, but that’s harsh
Tweet media one
5
0
35
@tnewsomdavis
Tom Newsom-Davis
8 months
Clear benefits of liquid biopsy in lung cancer in keeping with what we would expect Prospective real world data coming from ongoing @NHSEngland multi-centre pilot in 🇬🇧 For anyone who spends their time waiting for NGS results, this is a no-brainer @DrSanjayPopat
@ChristianRolfo
Christian Rolfo
8 months
Liquid Biopsy of Lung Cancer Before Pathological Diagnosis Is Associated With Shorter Time to Treatment ⁦ @JCOPO_ASCO ⁩ ⁦ @isliquidbiopsy ⁩ ⁦ @Al3ssandroRusso ⁩ ⁦ @Marzia_DelRe ⁩ ⁦ @geoff_oxnard ⁩ ⁦ @TischCancer ⁩ ⁦ @ASCO
1
26
81
2
7
35
@tnewsomdavis
Tom Newsom-Davis
2 years
Appropriate view from hotel for my welcome to Belfast #BTOG23
Tweet media one
6
0
35
@tnewsomdavis
Tom Newsom-Davis
5 months
Continuing immunotherapy beyond 2 years is not without risk 🚨50% develop late IRAE, post 2yrs 🚨60% of these had no pre-2yr IRAE 🚨Female, non-causcasian = higher risk Abstract 8551 #ASCO24 #LCSM
Tweet media one
0
15
35
@tnewsomdavis
Tom Newsom-Davis
4 years
Present from a lovely lady i have looked after for a few months but not very well and an inpatient at the moment. So kind. And a magnificent choice. 😋
Tweet media one
6
0
34
@tnewsomdavis
Tom Newsom-Davis
2 years
Best chemo accessory in clinic today
Tweet media one
1
2
35
@tnewsomdavis
Tom Newsom-Davis
4 years
Alex Lyon: Cardio-oncology Last talk of BTOG, but have saved best till last: 🔴 Many of our drugs are cardiotoxic 🔴 Range of cardiac toxicites 🔴 Osimertinib important here 🔴 5% immunotherapy patients affected #BTOG21
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
9
34
@tnewsomdavis
Tom Newsom-Davis
1 year
TRACERx continues to deliver fascinating results 🟡 Different growth rates of metastases according to site: pleura & soft tissue worst 🟡 Seeding subclone appearing on ctDNA prior to clinical relapse, and ultimately detected at autopsy Superb 🇬🇧 research 👏 #LCSM #ESMO23
Tweet media one
Tweet media two
0
11
33
@tnewsomdavis
Tom Newsom-Davis
5 years
(Self-isolation compliant) cycle ride with daughter. Found that one of the great minds of 20th century lived just down the road in Hampton. Died so young. Treated so badly.
Tweet media one
3
1
34
@tnewsomdavis
Tom Newsom-Davis
6 years
Pembrolizumab monotherapy gets additional EMA approval for a 6-weekly regimen (400mg). Should help with pressures on chemotherapy units, and be more convenient for patients. Data comes from modelling / simulation, as opposed to clinical studies.
3
15
33
@tnewsomdavis
Tom Newsom-Davis
5 years
Pembrolizumab fails where Durvalumab and Atezolizumab succeeded: no (statistically significant) improvement in OS in 1L ES-SCLC when added to platinum doublet chemotherapy. #LCSM @BTOGORG
5
16
32
@tnewsomdavis
Tom Newsom-Davis
1 year
DESTINY-Lung02: T-DXd @ 5.4 vs. 6.4mg/kg 👉 ORR = 40% vs. 56% 👉 DoR = 16.8m vs. NE 👉 mPFS = 9.4m vs. 15.4m 👉 mOS = 19.5m vs. NE 👉 AEs favour 5.4mg/kg dose 👉 ILD = 12.9% vs. 28% 5.4 is recommended dose going forward #LCSM #WCLC23
Tweet media one
Tweet media two
Tweet media three
1
16
32
@tnewsomdavis
Tom Newsom-Davis
2 years
What’s the diagnosis? (I am told it is rare to see on CXR)
Tweet media one
21
4
33
@tnewsomdavis
Tom Newsom-Davis
2 years
Excellent discussion on NADIM II: Interesting suggestion of superiority of carboplatin over cisplatin Given toxicity of cisplatin and long chair-time, I would be very happy to shift to carboplatin #LCSM #ASCO22 @BTOGORG
Tweet media one
0
12
33
@tnewsomdavis
Tom Newsom-Davis
5 months
@AlastairGreyst2 flying the flag for 🇬🇧 research at #ASCO24 with the outstanding CONCORDE study @finn_corinne
Tweet media one
2
6
34
@tnewsomdavis
Tom Newsom-Davis
5 years
FLAURA: Beyond headline OS data, other important findings relevant to countries struggling to get 1L Osimertinib funded: 🔶 30% of 1L EGFR TKI patients never receive any 2L treatment 🔶 40% of 1st generation EGFR TKI patients received 2L Osimertinib #ESMO2019 #LCSM
1
11
30
@tnewsomdavis
Tom Newsom-Davis
2 years
@gerryhanna @ASCO …and by Day 2, it gives an interesting poll of how we want to interact with colleagues. Elbow bumps win, it seems.
Tweet media one
1
2
30
@tnewsomdavis
Tom Newsom-Davis
6 months
Poster scrum 😍 #BTOG24
Tweet media one
2
2
32
@tnewsomdavis
Tom Newsom-Davis
2 years
From @BTOGORG Trainee Representative to fully-fledged plenary presenter: @AdamJanuszewski gives a beautifully clean and clear talk on controversies in NSCLC with driver mutations #BTOG23
Tweet media one
Tweet media two
0
7
32
@tnewsomdavis
Tom Newsom-Davis
4 months
1 month wait for NGS results unacceptable, but all too familiar I encourage colleagues to take advantage of @NHSEngland ctDNA pilot. This is greatly reducing wait times Just received +ve MET Ex14 result for patient I am not due to meet until next week! 👊
@EgfrUk
EGFR Positive Lung Cancer UK
4 months
New research confirms genomic testing is 🔑 to understand non-smokers with #lungcancer . Yet 40% of UK #EGFR + pts faced delays in mutation ID & only 40% were offered rebiopsy on progression. 🚨 Patients need better testing to benefit from advances & get effective treatment! #LCSM
Tweet media one
1
4
15
5
8
31
@tnewsomdavis
Tom Newsom-Davis
2 years
@StephenVLiu @JTOonline Being a 3rd generation TKI, can’t help thinking they should have called it Aftertertinib, not Befotertinib. (No need to thank me)
2
0
31
@tnewsomdavis
Tom Newsom-Davis
3 years
@rintoul_robert : estimated 5 year survival for lung cancer has fallen from 17.6% to 13% as consequence of COVID Upsetting news #BTOG22
5
23
31
@tnewsomdavis
Tom Newsom-Davis
2 years
TIL therapy in NSCLC: Clonal neo-antigens seem to drive response to immunotherapy As such, an important target fits TIL therapy
Tweet media one
1
9
31
@tnewsomdavis
Tom Newsom-Davis
6 months
Fabulous presentation from Michelle Rosario, our lung cancer CNS @ChelwestFT Beautifully clear description of benefits & challenges of running @NHSEngland ctDNA pilot Michelle has single handedly run this service: awesome 👏 #BTOG24 #LCSM
Tweet media one
Tweet media two
Tweet media three
3
5
31
@tnewsomdavis
Tom Newsom-Davis
4 years
First pint (from pub) since 2020 🤗
Tweet media one
4
0
31